"Hemophilia Pipeline Overview - Once-a-Week Prophylaxis May Soon Become a Reality" - New Market Report
Among the products for hemophilia A and B that are likely to reach the market within the next 4 years are modified recombinant factor replacements that could reduce injection frequencies significantly, making once-a-week prophylaxis a reality.
View full press release